載入...
SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. SET and MYND domain-containing protein 3 (SMYD3) has been shown to promote the progression of various types of human cancers, including liver cancer; however, the detailed molecular mechanism is still largely unknown. H...
Na minha lista:
| 發表在: | Cell Death Dis |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8302584/ https://ncbi.nlm.nih.gov/pubmed/34301921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-021-04009-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|